Search results for "Clavulanic Acid"

showing 10 items of 21 documents

Use of antibiotics by spanish dentists receiving postgraduate training in endodontics

2018

Background The incidence of endodontic infections is high. The contribution of Endodontics to the global problem of antibiotic resistance could be significant. The ESE, together with the World Health Organization, are promoting the World Antibiotic Awareness Week (13-19 November 2017) to promote the appropriate use of systemic antibiotics in Endodontics. The objective of this study was to determine the prescription pattern of antibiotics in the treatment of endodontic infections of Spanish dentists attending specialization programs in Endodontics. Material and Methods Dentists from five Spanish endodontic postgraduate programs were requested to answer a one-page questionnaire surveying abou…

0301 basic medicinemedicine.medical_specialtymedicine.drug_class030106 microbiologyAntibioticsDentistryAntibiòticsEndodonticsOperative Dentistry and Endodontics03 medical and health sciences0302 clinical medicineAntibiotic resistanceAntibioticsClavulanic acidmedicineEndodònciaMedical prescriptionEspanyaPeriodontitisGeneral Dentistrybusiness.industryResearchClindamycin030206 dentistryAmoxicillinEndodonticsPenicillinSpainbusinessmedicine.drugJournal of Clinical and Experimental Dentistry
researchProduct

Antibacterial susceptibility patterns of Porphyromonas gingivalis isolated from chronic Periodontitis patients

2010

Objectives: To test the antimicrobial sensitivity of Porphyromonas gingivalis to a panel of eight orally administrable antibiotics in chronic periodontal diseases and to evaluate factors associated with periodontitis in adult patients. Study Design: A total of fifty strains of P. gingivalis were isolated from one hundred and twenty adult patients with chronic perio-dontitis. Identification of bacteria was carried out by anaerobic culture and biochemical tests. Selected colonies of P. gingivalis were used to evaluate the antibacterial activities of penicillin, metronidazole, amoxicillin, amoxicillin/clavulanic acid, clindamycin, doxy-cycline, ciprofloxacin and azithromycin. Results: Most of …

AdultMalemedicine.drug_classAntibioticsAdministration OralMicrobial Sensitivity TestsAzithromycinMicrobiologyClavulanic acidmedicineHumansPeriodontitisGeneral DentistryPorphyromonas gingivalisPeriodontitisbiologybusiness.industryMiddle AgedAmoxicillin:CIENCIAS MÉDICAS [UNESCO]medicine.diseasebiology.organism_classificationChronic periodontitisAnti-Bacterial AgentsCiprofloxacinOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASChronic DiseaseFemaleSurgerybusinessPorphyromonas gingivalismedicine.drugMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Antimicrobial susceptibility of nine udder pathogens recovered from bovine clinical mastitis milk in Europe 2015–2016: VetPath results

2020

International audience; VetPath is an ongoing pan-European antimicrobial susceptibility monitoring programme collecting pathogens from diseased cattle, pigs and poultry not recently treated with antibiotics. Non-duplicate isolates (n = 1244) were obtained from cows with acute clinical mastitis in eight countries during 2015-2016 for centrally antimicrobial susceptibility testing according CLSI standards. Among Escherichia coli (n = 225), resistance was high to ampicillin and tetracycline, moderate to kanamycin and low to amoxicillin/clavulanic acid and cefazolin. The MIC50/90 of danofloxacin, enrofloxacin and marbofloxacin were 0.03 and 0.06 μg/mL. For Klebsiella spp. (n = 70), similar resu…

Cattle DiseasesMicrobial Sensitivity TestsBiologymedicine.disease_causeAntimicrobial resistanceMicrobiologyMicrobiology03 medical and health sciencesMammary Glands AnimalAntibiotic resistanceAmpicillinClavulanic acidDrug Resistance BacterialmedicineAnimalsDairy cattlePirlimycinMastitis Bovine030304 developmental biology0303 health sciencesSurveillanceBacteriaGeneral Veterinary030306 microbiologySCCmecMinimum inhibitory concentrationsGeneral Medicinebiochemical phenomena metabolism and nutritionmedicine.diseaseAnti-Bacterial Agents3. Good healthMastitisEuropePenicillinDairyingMilk[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyStreptococcus agalactiaeBacterial mastitis pathogensCattleFemale[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologymedicine.drug
researchProduct

Amperometric detection of extended-spectrum β-lactamase activity : application to the characterization of resistant E.coli strains

2015

EA MERS CT3; International audience; The amperometric detection of extended-spectrum β-lactamase (ESBL) with carbon screen-printed sensors was investigated in the presence of the Nitrocefin, a commercially-available β-lactamase chromogenic cephalosporin substrate. Using an ESBL isolated from a clinical sample, it was shown for the first time that the intensity of a specific anodic pic current (EP = [similar]+0.3 V vs. Ag/AgCl) resulting from the catalytic hydrolysis of the β-lactam ring was proportional to the amount of ESBL. The proof-of-principle of a novel susceptibility assay for the rapid and accurate identification of ESBL- producing bacteria was then demonstrated. The detection schem…

Cefotaximemedicine.drug_classélectrochimie[SDV]Life Sciences [q-bio]CephalosporinAnalytical chemistryBiochemistrybeta-LactamasesAnalytical Chemistry03 medical and health sciencesClavulanic acidDrug Resistance BacterialElectrochemistrymedicineEscherichia colipolycyclic compoundsEnvironmental ChemistryNitrocefin[SDV.BV]Life Sciences [q-bio]/Vegetal Biologyélectrode sérigraphiéeSpectroscopybêta-lactamase à spectre étendu (BLSE)Enzyme Assays030304 developmental biologyDetection limit0303 health sciencesChromatographybiology030306 microbiologyChemistryChromogenicbactériologienitrocéfineHydrolysisbiochemical phenomena metabolism and nutritionbiology.organism_classificationbacterial infections and mycosesAmperometryAnti-Bacterial AgentsCephalosporinscultureampérométrie[SDE]Environmental SciencesBacteriamedicine.drugbactériologie;culture;Escherichia coli;bêta-lactamase à spectre étendu (BLSE);électrochimie;ampérométrie;électrode sérigraphiée;nitrocéfine
researchProduct

Three simultaneous dissolution profiles on a solid pharmaceutical formulation by a FIA manifold provided with a single spectrophotometric detector.

2003

This article deals with the simultaneous determination of three dissolution profiles in the same pharmaceutical formulation. The officially proposed procedure from the pharmacopoeias is adapted to the FIA methodology to obtain the officially recommended profile or "global profile", and two "individual" profiles, corresponding to dissolution rate of two different active principles present in the formulation; both drugs have overlapped UV-vis spectra. The simultaneous determination of several profiles is based on the derivative spectra and the zero crossing mathematical procedure for the "individual" profiles of an active principle; the "global" profile of the formulation is obtained from the…

Chemistry PharmaceuticalClinical BiochemistryPharmaceutical ScienceDerivativePharmaceutical formulationPlot (graphics)Dosage formSpectral lineAnalytical ChemistryDrug DiscoveryApplied mathematicsSpectroscopyClavulanic AcidAntibacterial agentFlow injection analysisChromatographyChemistryAmoxicillinZero crossingBromhexinePharmaceutical SolutionsPharmaceutical PreparationsSolubilityFlow Injection AnalysisSpectrophotometry UltravioletTabletsJournal of pharmaceutical and biomedical analysis
researchProduct

Are the Adverse Drug Reactions of Amoxycillin and Amoxycillin-Clavulanic Acid Similar?

1996

UNLABELLED In an attempt to assess the relative toxicity of amoxycillin and amoxycillin-clavulanic acid, we compared the adverse drug reactions reports collected using the spontaneous reporting system of a Regional Drug Surveillance Centre of Spain for both drugs between November 1986 and December 1992. During the 7-year period 1986-92, the 247 reports of amoxycillin-clavulanic acid represent twice the number of reports of amoxycillin alone, and the number of reports related with sales received concerning the association were higher than those concerning amoxycillin alone. The adverse effects classified as severe were quantitatively and qualitatively similar for both drugs and gastrointesti…

Drugmedicine.medical_specialtyRelative toxicityEpidemiologybusiness.industrymedia_common.quotation_subjectAmoxycillin-Clavulanic AcidPharmacologyReporting rateInternal medicineSpontaneous reportingpolycyclic compoundsmedicinePharmacology (medical)Drug reactionAdverse effectbusinessmedia_commonPharmacoepidemiology and Drug Safety
researchProduct

In silico identification and experimental validation of hits active against KPC-2 β-lactamase

2018

Bacterial resistance has become a worldwide concern, particularly after the emergence of resistant strains overproducing carbapenemases. Among these, the KPC-2 carbapenemase represents a significant clinical challenge, being characterized by a broad substrate spectrum that includes aminothiazoleoxime and cephalosporins such as cefotaxime. Moreover, strains harboring KPC-type β-lactamases are often reported as resistant to available β-lactamase inhibitors (clavulanic acid, tazobactam and sulbactam). Therefore, the identification of novel non β-lactam KPC-2 inhibitors is strongly necessary to maintain treatment options. This study explored novel, non-covalent inhibitors active against KPC-2, …

Genetics and Molecular Biology (all)Proteomics0301 basic medicineCefotaximeKlebsiella pneumoniaePathology and Laboratory MedicinePhysical ChemistryBiochemistryKlebsiella PneumoniaeDatabase and Informatics MethodsBiochemistry Genetics and Molecular Biology (all); Agricultural and Biological Sciences (all)AntibioticsKlebsiellaCatalytic DomainMedicine and Health Sciencespolycyclic compoundsDrug InteractionsCrystallographyMultidisciplinarybiologyAntimicrobialsOrganic CompoundsProteomic DatabasesChemistryPhysicsQRDrugsSulbactamCondensed Matter PhysicsBacterial PathogensChemistryBiochemistryMedical MicrobiologyPhysical SciencesCrystal StructureMedicinePathogensbeta-Lactamase InhibitorsResearch Articlemedicine.drugScienceIn silico030106 microbiologySulfonamideResearch and Analysis MethodsMicrobiologyMeropenemTazobactambeta-Lactamases03 medical and health sciencesBacterial ProteinsMicrobial ControlClavulanic acidmedicineSolid State PhysicsMicrobial PathogensPharmacologyLigand efficiencyChemical BondingBacteriaOrganic ChemistryChemical CompoundsOrganismsBiology and Life SciencesHydrogen Bondingbiochemical phenomena metabolism and nutritionbiology.organism_classificationbacterial infections and mycosesAmidesBiological Databases030104 developmental biologyAgricultural and Biological Sciences (all)
researchProduct

Enterobacter and Klebsiella species isolated from fresh vegetables marketed in Valencia (Spain) and their clinically relevant resistances to chemothe…

2013

Occurrence of antibiotic-resistant pathogenic or commensal enterobacteria in marketed agricultural foodstuffs may contribute to their incorporation into the food chain and constitutes an additional food safety concern. In this work, we have determined the clinically relevant resistances to 11 common chemotherapeutic agents in Enterobacter and Klebsiella isolates from fresh vegetables from various sources (supermarkets and greengrocers' shops in Valencia, Spain). A total of 96 isolates were obtained from 160 vegetables analyzed (50% positive samples): 68 Enterobacter isolates (59 E. cloacae, two E. aerogenes, two E. cancerogenus, one E. gergoviae, and four E. sakazakii, currently Cronobacter…

KlebsiellaFood SafetyEnterobacterCeftazidimeFood ContaminationMicrobial Sensitivity TestsApplied Microbiology and BiotechnologyMicrobiologyMicrobiologyClavulanic acidKlebsiellaDrug Resistance BacterialVegetablesmedicinePrevalenceHumansCronobacterbiologyEnterobacteriaceae InfectionsEnterobacterbiology.organism_classificationAnti-Bacterial AgentsCiprofloxacinSpainAnimal Science and ZoologyGentamicinFood Sciencemedicine.drugFood contaminantFoodborne pathogens and disease
researchProduct

DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?

2014

Background. Morbidity and mortality for critically ill patients with infections remains a global healthcare problem. We aimed to determine whether α-lactam antibiotic dosing in critically ill patients achieves concentrations associated with maximal activity and whether antibiotic concentrations affect patient outcome.Methods. This was a prospective, multinational pharmacokinetic point-prevalence study including 8 α-lactam antibiotics. Two blood samples were taken from each patient during a single dosing interval. The primary pharmacokinetic/pharmacodynamic targets were free antibiotic concentrations above the minimum inhibitory concentration (MIC) of the pathogen at both 50% (50% f TMIC) an…

MaleInternational CooperationAntibioticsadverse eventintensive care unitlaw.invention0302 clinical medicinemeropenemModels[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesadverse events; continuous infusion; extended infusion; pharmacodynamics; pharmacokinetics; Aged; Anti-Bacterial Agents; Bacterial Infections; Blood Chemical Analysis; Female; Humans; Intensive Care Units; International Cooperation; Male; Microbial Sensitivity Tests; Middle Aged; Models Statistical; Prospective Studies; Treatment Outcome; beta-Lactams; Critical Illnessantibiotic therapyProspective Studiesamoxicillin plus clavulanic acidComputingMilieux_MISCELLANEOUSbeta lactam antibioticAPACHE0303 health sciencescritical illneadultclinical trial3. Good healthcontinuous infusion; extended infusion; adverse events; pharmacokinetics; pharmacodynamics.antiinfective agent[SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitologypriority journaldisease severitybeta-Lactamstatistical model Agedprospective studyHumanMicrobiology (medical)medicine.medical_specialtydrug exposureCritical IllnessImmunologybloodstream infectionMicrobial Sensitivity Testspiperacillin plus tazobactambeta-LactamsMicrobiologybeta lactam abdominal infection03 medical and health sciencescritically ill patientIntensive careAnti-Bacterial AgentcefepimepharmacodynamicsHumansDosingAdverse effectAgedModels Statistical030306 microbiologyOdds ratiomajor clinical studymortalityantibiotic sensitivityceftriaxoneProspective Studiemulticenter studypharmacodynamics.ampicillinBlood Chemical AnalysisCeftazidimeSettore MED/41 - AnestesiologiaInterquartile rangelaw030212 general & internal medicinepharmacokineticlung infectionMicrobial Sensitivity TestarticleBacterial InfectionsMiddle AgedStatisticalcontinuous infusionIntensive care unitAnti-Bacterial Agentsextended infusionIntensive Care UnitsInfectious DiseasesTreatment Outcomeadverse events; continuous infusion; extended infusion; pharmacodynamics; pharmacokinetics; Aged; Anti-Bacterial Agents; Bacterial Infections; Blood Chemical Analysis; Female; Humans; Intensive Care Units; International Cooperation; Male; Microbial Sensitivity Tests; Middle Aged; Models Statistical; Prospective Studies; Treatment Outcome; beta-Lactams; Critical Illness; Microbiology (medical); Infectious Diseasescefazolin[SDV.IMM]Life Sciences [q-bio]/Immunologyblood samplingFemalepharmacokineticsmedicine.drugmedicine.drug_classprevalencedoripenemminimum inhibitory concentrationBacterial InfectionInternal medicinemedicinecontrolled studyblood analysibusiness.industryBlood Chemical Analysiadverse eventsSurgerypharmacodynamicdrug blood levelbusiness
researchProduct

Hypersensitivity to clavulanic acid in children

2008

We present 10 cases (6 males and 4 females) of children aged 4 to 12 years, who were diagnosed with allergy to clavulanic acid (CL) and treated in the Paediatric Allergy Section of the University Hospital Dr. Peset in Valencia from 2000 to 2005. The children reported symptoms of urticaria and angio-oedema after receiving orally-administered amoxicillin/clavulanic acid (A-CL) for an infection. Diagnosis was based on the confirmation of an IgE-mediated aetiology by an oral challenge test with amoxicillin-clavulanic acid. Following negative skin test results and CAP for penicilloyl G and V, amoxicillin, ampicillin and cefaclor < 0.35 KU/l, those patients who were allergic to clavulanic acid (p…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyAllergyImmunologyAdministration OralImmunoglobulin EGastroenterologyDrug HypersensitivityClavulanic acidInternal medicineAmpicillinmedicineHumansImmunology and AllergyChildClavulanic AcidRetrospective StudiesSkin Testsbiologybusiness.industryGeneral MedicineImmunoglobulin EAmoxicillinmedicine.diseaseAnti-Bacterial AgentsSurgeryNegative Skin TestChild Preschoolbiology.proteinFemalebusinessCefuroximeCefaclormedicine.drugAllergologia et Immunopathologia
researchProduct